logo
  Home | Contact us | Browse | Quick Search by UniProtKB ID, Keyword, PDBID

Menu:

Latest news:

Sep. 10, 2014:
A total of 174 experimentally verified S-nitrosylation sites on 94 S-nitrosylated proteins from individualized human colorectal cancer tissues using a label-free quantitation strategy.

Read more...


Protein Name: Transitional endoplasmic reticulum ATPase

UniprotKB/SwissProt ID: TERA_MOUSE (Q01853)

Gene Name: Vcp

Organism: Mus musculus (Mouse).

Function: Necessary for the fragmentation of Golgi stacks during mitosis and for their reassembly after mitosis. Involved in the formation of the transitional endoplasmic reticulum (tER). The transfer of membranes from the endoplasmic reticulum to the Golgi apparatus occurs via 50-70 nm transition vesicles which derive from part-rough, part-smooth transitional elements of the endoplasmic reticulum (tER). Vesicle budding from the tER is an ATP-dependent process. The ternary complex containing UFD1L, VCP and NPLOC4 binds ubiquitinated proteins and is necessary for the export of misfolded proteins from the ER to the cytoplasm, where they are degraded by the proteasome. The NPLOC4-UFD1L-VCP complex regulates spindle disassembly at the end of mitosis and is necessary for the formation of a closed nuclear envelope. Regulates E3 ubiquitin-protein ligase activity of RNF19A (By similarity). Component of the VCP/p97-AMFR/gp78 complex that participates in the final step of the sterol-mediated ubiquitination and endoplasmic reticulum-associated degradation (ERAD) of HMGCR. Also involved in DNA damage response: recruited to double-strand breaks (DSBs) sites in a RNF8- and RNF168- dependent manner and promotes the recruitment of TP53BP1 at DNA damage sites. Recruited to stalled replication forks by SPRTN: may act by mediating extraction of DNA polymerase eta (POLH) to prevent excessive translesion DNA synthesis and limit the incidence of mutations induced by DNA damage (By similarity).

Other Modifications: View all modification sites in dbPTM

Protein Subcellular Localization: Cytoplasm, cytosol. Nucleus. Endoplasmic reticulum (By similarity). Note=Recruited to the cytoplasmic surface of the endoplasmic reticulum via interaction with AMFR/gp78. Following DNA double-strand breaks, recruited to the sites of damage. Recruited to

PDB :
( If your security settings prevent Jmol from running, please register http://140.138.144.145/ as a safe location in your Java settings. )

Network with metabolic pathway:
Kegg map ID Pathway Link
map05134Legionellosis
map04141Protein processing in endoplasmic reticulum
Graphical Visualization of S-nitrosylation Sites:
Overview of Protein S-nitrosylation Sites with Functional and Structural Information
InterPro ID Domain
IPR003338
IPR003593
IPR003959
IPR003960
IPR005938
IPR009010

3D Structure Databases:
3D structure databases
EntryMethodResolution (A)ChainPositionsView
1E32 X-ray 2.90 A A1-458Link
1R7R X-ray 3.60 A A1-806Link
1S3S X-ray 2.90 A A/B/C/D/E/F1-458Link
2PJH NMR - B21-213Link
3CF0 X-ray 3.00 A A/B/C/D/E/F/G/H/I/J/K/L/M/N463-763Link
3CF1 X-ray 4.40 A A/B/C1-806Link
3CF2 X-ray 3.50 A A/B/C/D1-806Link
3CF3 X-ray 4.25 A A/B/C1-806Link

The S-nitrosylation sites of TERA_MOUSE

No. Position S-nitrosylated Peptide Secondary Structure of S-nitrosylated Peptide Solvent Accessibility of nitrosylated Site Substrate Motifs PubMed ID Experiment
1105RLGDVISIQP C PDVKYGKRIH CCCCCEEEEE C CCCCCCCEEE 2.29%MC0520925432in vivo
2105RLGDVISIQP C PDVKYGKRIH CCCCCEEEEE C CCCCCCCEEE 2.29%MC0521278135in vitro
3174KVVETDPSPY C IVAPDTVIHC HHHHHCCCCC C CCCCCCCCCC 1.98%MC0320925432in vivo
4209NEVGYDDIGG C RKQLAQIKEM CCCCHHHHCC H HHHHHHHHHH 4.07%MC0620925432in vivo
5522KGVLFYGPPG C GKTLLAKAIA CCEEEECCCC C CHHHHHHHHH 6.61%MC0522865876in vivo
6535TLLAKAIANE C QANFISIKGP HHHHHHHHHH C CCCEEEEEHH 4.67%MC1322588120-
7535TLLAKAIANE C QANFISIKGP HHHHHHHHHH C CCCEEEEEHH 4.67%MC1320925432in vivo
8535TLLAKAIANE C QANFISIKGP HHHHHHHHHH C CCCEEEEEHH 4.67%MC1321278135in vitro
9535TLLAKAIANE C QANFISIKGP HHHHHHHHHH C CCCEEEEEHH 4.67%MC1322865876in vivo
10572IFDKARQAAP C VLFFDELDSI HHHHHHHCCC C EEEEECHHHH 3.40%MC0120925432in vivo
11572IFDKARQAAP C VLFFDELDSI HHHHHHHCCC C EEEEECHHHH 3.40%MC0121278135in vitro
12572IFDKARQAAP C VLFFDELDSI HHHHHHHCCC C EEEEECHHHH 3.40%MC0122865876in vivo
13691GFSGADLTEI C QRACKLAIRE CCCHHHHHHH H HHHHHHHHHH 1.50%MC0320925432in vivo
14691GFSGADLTEI C QRACKLAIRE CCCHHHHHHH H HHHHHHHHHH 1.50%MC0321278135in vitro
15691GFSGADLTEI C QRACKLAIRE CCCHHHHHHH H HHHHHHHHHH 1.50%MC0322865876in vivo